Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
11
×
boston blog main
boston top stories
deals
11
×
fda
11
×
investing
11
×
life sciences
national blog main
national top stories
11
×
san francisco blog main
san francisco top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
startups
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
pfizer
roche
duchenne muscular dystrophy
eli lilly
europe blog main
europe top stories
What
roundup
bio
cancer
days
develop
drug
fda
ahead
amid
asco
biotech
bombast
caught
companies
coronavirus
debate
digital
discussion
drugs
efforts
growing
life
meso’s
miss
new
pandemic
pfizer’s
presidential
promise
raised
response
science
startup
time
tuesday’s
vaccine
viewers
acquire
adding
alliance
Language
unset
Current search:
biotech
×
deals
×
investing
×
fda
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More